OnKure Therapeutics, Inc.
Biotechnology
Healthcare
OKUR
13.51 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
2.68
52 week high
19.21
high
2.76
52 week low
0.00
low
2.51
growth
-83.13 %
previous Close
2.61
P/E ratio
-2
market cap
76.57 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
-15.39 M
3.36 %
eps
-1.14 %
3.97 %
eps surprise
0.00 %
net profit margin
-1539000000.00 %
0.00 %
operating incoming
-16.32 M
3.98 %
net change in cash
-13.29 M
5.77 %
cash on hand
83.37 M
-13.75 %
cost of revenue
212 K
0.00 %
top top